Kadriye Erdoğan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kadriye Erdoğan has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Yaprak Engin-Ustun
Izmir City Hospital
11 shared publications - Nazli Tunca Sanlier
Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey
9 shared publications - Inci Kahyaoglu
Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Türkiye
7 shared publications - Serdar Dilbaz
UNIVERSITY OF HEALTH SCIENCES, ANKARA ETLİK ZÜBEYDE HANIM HEALTH RESEARCH CENTER FOR GYNECOLOGICAL DISEASES
5 shared publications - Emine Utlu Özen
UNIVERSITY OF HEALTH SCIENCES, ANKARA ETLİK ZÜBEYDE HANIM HEALTH RESEARCH CENTER FOR GYNECOLOGICAL DISEASES
4 shared publications - Busra Korpe
Ankara Etlik Şehir Hastanesi
3 shared publications
Latest Publications
- Open Access
- 10 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1375
Evaluation of the Relationship Between Adenomyosis and Cervical Elastography Parameters
Objectives: We aim to investigate cervical biomechanical alterations associated with adenomyosis using shear-wave elastography (SWE), and to explore the discriminative potential of cervical SWE parameters. Methods: In this prospective study, 84 patients with adenomyosis, diagnosed both clinically and by ultrasonography according to the MUSA parameters, and 65 healthy women underwent elastography to the cervix with SWE. Six areas of the cervix were evaluated: anterior and posterior internal os, middle part of the cervix, and external os. Results: The adenomyosis group showed a significantly higher cervical length (27.3 ± 5.5 mm vs. 23.8 ± 4.6 mm), as well as greater anterior (11.3 ± 2.4 mm vs. 9.9 ± 1.3 mm) and posterior (11.3 ± 2.2 mm vs. 10.5 ± 1.8 mm) cervical measurements compared with the controls (p < 0.001). SWE showed higher stiffness measurements for the anterior and posterior internal os (22.3 ± 5.4 kPa and 22.2 ± 4.9 kPa) compared with the controls (15.5 ± 5.8 kPa and 15.7 ± 5.6 kPa, respectively; p < 0.001). Receiver operating characteristic analysis demonstrated high discrimination for these measurements, with area under curve values of 0.804 for the anterior internal os and 0.808 of posterior internal os. Optimal cut-offs were 17.5 kPa (sensitivity 82%, specificity 70%) and 18.5 kPa (sensitivity 81%, specificity 74%). Conclusions: Cervical elastography may serve as a non-invasive adjunctive tool for exploring disease-related biomechanical changes and for supporting imaging-based assessment of adenomyosis.
- 10 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1375
Open AccessEvaluation of the Relationship Between Adenomyosis and Cervical Elastography Parameters
Objectives: We aim to investigate cervical biomechanical alterations associated with adenomyosis using shear-wave elastography (SWE), and to explore the discriminative potential of cervical SWE parameters. Methods: In this prospective study, 84 patients with adenomyosis, diagnosed both clinically and by ultrasonography according to the MUSA parameters, and 65 healthy women underwent elastography to the cervix with SWE. Six areas of the cervix were evaluated: anterior and posterior internal os, middle part of the cervix, and external os. Results: The adenomyosis group showed a significantly higher cervical length (27.3 ± 5.5 mm vs. 23.8 ± 4.6 mm), as well as greater anterior (11.3 ± 2.4 mm vs. 9.9 ± 1.3 mm) and posterior (11.3 ± 2.2 mm vs. 10.5 ± 1.8 mm) cervical measurements compared with the controls (p < 0.001). SWE showed higher stiffness measurements for the anterior and posterior internal os (22.3 ± 5.4 kPa and 22.2 ± 4.9 kPa) compared with the controls (15.5 ± 5.8 kPa and 15.7 ± 5.6 kPa, respectively; p < 0.001). Receiver operating characteristic analysis demonstrated high discrimination for these measurements, with area under curve values of 0.804 for the anterior internal os and 0.808 of posterior internal os. Optimal cut-offs were 17.5 kPa (sensitivity 82%, specificity 70%) and 18.5 kPa (sensitivity 81%, specificity 74%). Conclusions: Cervical elastography may serve as a non-invasive adjunctive tool for exploring disease-related biomechanical changes and for supporting imaging-based assessment of adenomyosis.
- 14 June 2025
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- p. 1-10
Fetal NT-proBNP Concentrations in Response to Maternal Anemia: A Study of Term Pregnancies
This study evaluates fetal N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in umbilical cord blood from anemic versus non-anemic term pregnancies. In this prospective case-control study, 90 pregnant women were divided into two groups: 45 with maternal anemia and 45 without. Umbilical cord blood NT-proBNP concentrations were analyzed, and maternal data including hemoglobin and ferritin levels were collected. NT-proBNP concentrations were significantly higher in the anemia group (844.42 ± 746.9 pg/mL vs 510.87 ± 378.52 pg/mL, p = 0.01). Maternal ferritin levels were significantly lower in the anemia group (10.02 ± 6.81 vs 37.02 ± 9.79, p < 0.001). A significant inverse relationship was found between hemoglobin and NT-proBNP concentrations (β = -76.27, p < 0.001). Elevated NT-proBNP concentrations in anemic pregnancies suggest a compensatory fetal response to hypoxia, highlighting its potential as a marker for fetal cardiovascular adaptation.
- 14 June 2025
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- p. 1-10
Fetal NT-proBNP Concentrations in Response to Maternal Anemia: A Study of Term Pregnancies
This study evaluates fetal N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in umbilical cord blood from anemic versus non-anemic term pregnancies. In this prospective case-control study, 90 pregnant women were divided into two groups: 45 with maternal anemia and 45 without. Umbilical cord blood NT-proBNP concentrations were analyzed, and maternal data including hemoglobin and ferritin levels were collected. NT-proBNP concentrations were significantly higher in the anemia group (844.42 ± 746.9 pg/mL vs 510.87 ± 378.52 pg/mL, p = 0.01). Maternal ferritin levels were significantly lower in the anemia group (10.02 ± 6.81 vs 37.02 ± 9.79, p < 0.001). A significant inverse relationship was found between hemoglobin and NT-proBNP concentrations (β = -76.27, p < 0.001). Elevated NT-proBNP concentrations in anemic pregnancies suggest a compensatory fetal response to hypoxia, highlighting its potential as a marker for fetal cardiovascular adaptation.
- Open Access
- 30 April 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (1) , 35-40
Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors
Aim: This study aimed to evaluate the prevalence of gastrointestinal (GI) symptoms during pregnancy and identify hormonal, nutritional, and lifestyle factors contributing to their severity. Material and Methods: The study was conducted involving 612 pregnant women aged 20 to 40 years, with gestational ages between 5 and 36 weeks. Participants were categorized into three groups based on their trimester. GI symptoms were assessed using the gastrointestinal symptom rating scale (GSRS). A structured questionnaire was used to collect data on demographic characteristics, obstetric history, prior GI conditions, and lifestyle factors. Results: The study found that indigestion (77.6%, n=475), reflux (68.5%, n=419), and abdominal pain (69.9%, n=428) were the most common GI symptoms reported. While indigestion (78.4%, n=171) followed by nausea (76.1%, n=166) was the most common symptoms in the first trimester, abdominal pain (78.1%, n=171) and reflux (76.3%, n=167) were most frequent in the second trimester, In the third trimester, indigestion (81.1%, n=142) was again the most common symptom, followed by reflux (76.6%, n=134). High GSRS scores were found to be significantly associated with excessive tea consumption (OR: 4.22, 95% CI: 1.44-12.35, p<0.001), employment status (OR: 2.32, 95% CI: 1.63-3.32, p<0.001), and TSH levels (OR: 1.26, 95% CI: 1.13-1.41, p<0.001). Conclusion: GI symptoms are highly prevalent during pregnancy and are influenced by modifiable factors such as tea consumption, weight gain, and work-related stress. Monitoring thyroid function, managing weight, reducing tea intake, and addressing stress may help alleviate these symptoms, thereby improving the quality of life for pregnant women.
- 30 April 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (1) , 35-40
Open AccessGastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors
Aim: This study aimed to evaluate the prevalence of gastrointestinal (GI) symptoms during pregnancy and identify hormonal, nutritional, and lifestyle factors contributing to their severity. Material and Methods: The study was conducted involving 612 pregnant women aged 20 to 40 years, with gestational ages between 5 and 36 weeks. Participants were categorized into three groups based on their trimester. GI symptoms were assessed using the gastrointestinal symptom rating scale (GSRS). A structured questionnaire was used to collect data on demographic characteristics, obstetric history, prior GI conditions, and lifestyle factors. Results: The study found that indigestion (77.6%, n=475), reflux (68.5%, n=419), and abdominal pain (69.9%, n=428) were the most common GI symptoms reported. While indigestion (78.4%, n=171) followed by nausea (76.1%, n=166) was the most common symptoms in the first trimester, abdominal pain (78.1%, n=171) and reflux (76.3%, n=167) were most frequent in the second trimester, In the third trimester, indigestion (81.1%, n=142) was again the most common symptom, followed by reflux (76.6%, n=134). High GSRS scores were found to be significantly associated with excessive tea consumption (OR: 4.22, 95% CI: 1.44-12.35, p<0.001), employment status (OR: 2.32, 95% CI: 1.63-3.32, p<0.001), and TSH levels (OR: 1.26, 95% CI: 1.13-1.41, p<0.001). Conclusion: GI symptoms are highly prevalent during pregnancy and are influenced by modifiable factors such as tea consumption, weight gain, and work-related stress. Monitoring thyroid function, managing weight, reducing tea intake, and addressing stress may help alleviate these symptoms, thereby improving the quality of life for pregnant women.
- Open Access
- 11 March 2025
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 34 (11)
Preoperative hemoglobin A1c as a predictor of lymph node metastasis in diabetic women with endometrial cancer
Glycated hemoglobin A1c (HbA1c) is a well-established marker for glycemic control; recent studies suggest its potential role in cancer prognosis. Understanding the relationship between preoperative HbA1c levels and lymph node metastasis (LNM) in diabetic women with endometrial cancer (EC) can enhance prognostic assessments and treatment strategies. This study aimed to evaluate the predictive value of preoperative HbA1c levels for LNM in diabetic women with EC. A retrospective analysis was conducted on 233 diabetic women who underwent surgery for endometrioid-type EC at a tertiary referral hospital between 2010 and 2021. Data collected included demographic information, fasting plasma glucose, HbA1c levels, ultrasound findings, and tumor characteristics. Receiver operating characteristic (ROC) analysis was used to assess the predictive power of HbA1c levels for LNM. Univariate and multivariate regression analyses were performed to identify independent risk factors for LNM. The mean preoperative HbA1c level was 7.03 ±1.37%. A cutoff HbA1c level ≥7.26% demonstrated a sensitivity of 73.7%, a specificity of 72.3% and an area under the curve (AUC) of 0.781 for predicting LNM (p < 0.001). Significant correlations were found between HbA1c levels and endometrial thickness (r = 0.231, p < 0.001), primary tumor diameter (PTD) (r = 0.173, p = 0.008) and duration of diabetes (r = 0.203, p = 0.002). Multivariate analysis identified HbA1c level (odds ratio (OR) = 2.621, 95% confidence interval (95% CI): 1.722-3.987, p < 0.001), lymphovascular space involvement (LVSI) (OR = 19.193, 95% CI: 5.805-63.458, p < 0.001), body mass index (BMI) (OR = 1.095, 95% CI: 1.010-1.188, p = 0.029), and duration of diabetes (OR = 1.019, 95% CI: 1.001-1.301, p = 0.039) as independent risk factors for LNM. Preoperative HbA1c levels serve as a significant predictor for LNM in diabetic women with EC. A cutoff HbA1c level ≥7.26% indicates higher risk of LNM. These findings underscore the importance of glycemic control in reducing cancer progression risks and improving the prognosis of diabetic patients with EC. Integrating HbA1c monitoring into preoperative assessments can help tailor personalized treatment strategies for better outcomes.
- 11 March 2025
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 34 (11)
Open AccessPreoperative hemoglobin A1c as a predictor of lymph node metastasis in diabetic women with endometrial cancer
Glycated hemoglobin A1c (HbA1c) is a well-established marker for glycemic control; recent studies suggest its potential role in cancer prognosis. Understanding the relationship between preoperative HbA1c levels and lymph node metastasis (LNM) in diabetic women with endometrial cancer (EC) can enhance prognostic assessments and treatment strategies. This study aimed to evaluate the predictive value of preoperative HbA1c levels for LNM in diabetic women with EC. A retrospective analysis was conducted on 233 diabetic women who underwent surgery for endometrioid-type EC at a tertiary referral hospital between 2010 and 2021. Data collected included demographic information, fasting plasma glucose, HbA1c levels, ultrasound findings, and tumor characteristics. Receiver operating characteristic (ROC) analysis was used to assess the predictive power of HbA1c levels for LNM. Univariate and multivariate regression analyses were performed to identify independent risk factors for LNM. The mean preoperative HbA1c level was 7.03 ±1.37%. A cutoff HbA1c level ≥7.26% demonstrated a sensitivity of 73.7%, a specificity of 72.3% and an area under the curve (AUC) of 0.781 for predicting LNM (p < 0.001). Significant correlations were found between HbA1c levels and endometrial thickness (r = 0.231, p < 0.001), primary tumor diameter (PTD) (r = 0.173, p = 0.008) and duration of diabetes (r = 0.203, p = 0.002). Multivariate analysis identified HbA1c level (odds ratio (OR) = 2.621, 95% confidence interval (95% CI): 1.722-3.987, p < 0.001), lymphovascular space involvement (LVSI) (OR = 19.193, 95% CI: 5.805-63.458, p < 0.001), body mass index (BMI) (OR = 1.095, 95% CI: 1.010-1.188, p = 0.029), and duration of diabetes (OR = 1.019, 95% CI: 1.001-1.301, p = 0.039) as independent risk factors for LNM. Preoperative HbA1c levels serve as a significant predictor for LNM in diabetic women with EC. A cutoff HbA1c level ≥7.26% indicates higher risk of LNM. These findings underscore the importance of glycemic control in reducing cancer progression risks and improving the prognosis of diabetic patients with EC. Integrating HbA1c monitoring into preoperative assessments can help tailor personalized treatment strategies for better outcomes.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 20 (5) , 1
Relevance of Infertility, Epigenetics, Nutrient, and Bioactive Components: A Review of the Literature
Background: This review discusses epigenetic mechanisms and the relationship of infertility in men and women in relation to parameters pertaining to nutrition. Methods: A review of the line of the literature was conducted prior to June 2021 through the selected websites, including MEDLINE, Embase, Web of Science, www.ClinicalTrials.gov, Cochrane Central, PubMed, Google Scholar, Science Direct, and the WHO. Results: The prevalence of infertility worldwide is 8-12%, and one out of every 8 couples receives medical treatment. Epigenetic mechanisms, aging, environmental factors, dietary energy and nutrients and non-nutrient compounds; more or less energy intake, and methionine play a role in the onset of infertility. Furthermore, more factors that contribute to infertility include the vitamins B12, D, and B6, biotin, choline, selenium, zinc, folic acid, resveratrol, quercetin, and others.. Discussion: To understand the molecular mechanisms regulating the expression of genes that affect infertility, the environment, the role of genotype, age, health, nutrition, and changes in the individual's epigenotype must first be considered. This will pave the way for the identification of the unknown causes of infertility. Insufficient or excessive intake of energy and certain macro and micronutrients may contribute to the occurrence of infertility as well. In addition, it is reported that 5-10% of body weight loss, moderate physical activity and nutritional interventions for improvement in insulin sensitivity contribute to the development of fertility. Conclusion: Epigenetic processes involve inherited changes but not encoded by the DNA sequence itself. Nutrition is thought to affect the epigenetic mechanisms that play a role in the pathogenesis of many diseases, including infertility. Epigenetic mechanisms of individuals with infertility are different from healthy individuals. Infertility is associated with epigenetic mechanisms, nutrients, bioactive components and numerous other factors.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 20 (5) , 1
Relevance of Infertility, Epigenetics, Nutrient, and Bioactive Components: A Review of the Literature
Background: This review discusses epigenetic mechanisms and the relationship of infertility in men and women in relation to parameters pertaining to nutrition. Methods: A review of the line of the literature was conducted prior to June 2021 through the selected websites, including MEDLINE, Embase, Web of Science, www.ClinicalTrials.gov, Cochrane Central, PubMed, Google Scholar, Science Direct, and the WHO. Results: The prevalence of infertility worldwide is 8-12%, and one out of every 8 couples receives medical treatment. Epigenetic mechanisms, aging, environmental factors, dietary energy and nutrients and non-nutrient compounds; more or less energy intake, and methionine play a role in the onset of infertility. Furthermore, more factors that contribute to infertility include the vitamins B12, D, and B6, biotin, choline, selenium, zinc, folic acid, resveratrol, quercetin, and others.. Discussion: To understand the molecular mechanisms regulating the expression of genes that affect infertility, the environment, the role of genotype, age, health, nutrition, and changes in the individual's epigenotype must first be considered. This will pave the way for the identification of the unknown causes of infertility. Insufficient or excessive intake of energy and certain macro and micronutrients may contribute to the occurrence of infertility as well. In addition, it is reported that 5-10% of body weight loss, moderate physical activity and nutritional interventions for improvement in insulin sensitivity contribute to the development of fertility. Conclusion: Epigenetic processes involve inherited changes but not encoded by the DNA sequence itself. Nutrition is thought to affect the epigenetic mechanisms that play a role in the pathogenesis of many diseases, including infertility. Epigenetic mechanisms of individuals with infertility are different from healthy individuals. Infertility is associated with epigenetic mechanisms, nutrients, bioactive components and numerous other factors.
- Open Access
- 1 July 2024
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 16, 1249-1256
Metabolic Syndrome and Menopause: The Impact of Menopause Duration on Risk Factors and Components
Purpose: This study was undertaken to investigate the impact of menopause duration on the risk factors and components of metabolic syndrome (MetS). Patients and Methods: Women aged between 45 and 60 years participated in the study. Participants were split into two groups based on the duration of menopause. Women who had been menopausal for 1 to ≤ 5 years constituted Group 1, while women with 6– 10 years of menopause duration formed Group 2. Results: Significant differences were observed between the two groups for various factors associated with MetS, including anthropometric measurements, biochemical markers, and blood pressure. The conicity index, weight-to-hip ratio, waist-to-height ratio, visceral adiposity index (VAI), and menopause duration were associated with increased risk of MetS. Our multivariate logistic regression model showed that women with elevated VAI had a 2.073-fold (95% CI: 1.73– 2.48, p< 0.001) increased risk of MetS, while women with menopause duration more than 5 years had a 6.44-fold (95% CI: 3.336– 12.45, p< 0.001) increased risk of MetS. Conclusion: The duration of menopause was found to be linked to a higher risk of MetS. Our results emphasize the importance of monitoring and managing metabolic health in women during the menopausal period, particularly those with extended menopause duration.
- 1 July 2024
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 16, 1249-1256
Open AccessMetabolic Syndrome and Menopause: The Impact of Menopause Duration on Risk Factors and Components
Purpose: This study was undertaken to investigate the impact of menopause duration on the risk factors and components of metabolic syndrome (MetS). Patients and Methods: Women aged between 45 and 60 years participated in the study. Participants were split into two groups based on the duration of menopause. Women who had been menopausal for 1 to ≤ 5 years constituted Group 1, while women with 6– 10 years of menopause duration formed Group 2. Results: Significant differences were observed between the two groups for various factors associated with MetS, including anthropometric measurements, biochemical markers, and blood pressure. The conicity index, weight-to-hip ratio, waist-to-height ratio, visceral adiposity index (VAI), and menopause duration were associated with increased risk of MetS. Our multivariate logistic regression model showed that women with elevated VAI had a 2.073-fold (95% CI: 1.73– 2.48, p< 0.001) increased risk of MetS, while women with menopause duration more than 5 years had a 6.44-fold (95% CI: 3.336– 12.45, p< 0.001) increased risk of MetS. Conclusion: The duration of menopause was found to be linked to a higher risk of MetS. Our results emphasize the importance of monitoring and managing metabolic health in women during the menopausal period, particularly those with extended menopause duration.
- Open Access
- 26 April 2024
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 44 (1) , 2346228
Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception
Background: Prolidase is a manganese (Mn)-dependent cytosolic exopeptidase that degrades imidodipeptides with C-terminal proline or hydroxyproline. Prolidase recycling from imidodipeptides plays a critical role in collagen resynthesis and extracellular matrix (ECM) remodelling. Following an increase in gonadotropins, ovarian and follicular collagen undergo substantial degradation. Abnormal ovarian ECM composition is associated with polycystic ovary syndrome (PCOS). This study aimed to examine prolidase activity in the serum and follicular fluid (FF) of women undergoing in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) treatment, comparing those with PCOS to those with normal ovarian function.Methods: This prospective study enrolled 50 participants, of whom 44 were included. PCOS diagnosis followed the Rotterdam consensus criteria, with 20 patients constituting the study group. The control group comprised 24 individuals with mild-to-moderate male infertility. Prolidase enzyme activity in serum and FF was measured using the Chinard reagent via spectrophotometric analysis and compared between the groups.Results: Serum and FF prolidase levels were significantly lower in patients with PCOS (p < 0.05). A direct correlation was observed between serum and FF prolidase levels (p < 0.05). Although blastocyst quality scoring (BQS) significantly decreased in PCOS patients, no statistical difference was observed in the clinical pregnancy rate between the groups (p < 0.05) (p > 0.05). A negative correlation existed between serum prolidase levels and total antral follicle (AF) count (p < 0.05). Conversely, both serum and FF prolidase levels positively correlated with BQS (r = 0.574)(p < 0.05) (r = 0.650)(p < 0.05).Conclusions: Patients with PCOS showed lower serum and FF prolidase levels, indicating abnormal degradation of ovarian and follicular collagen, potentially causing anovulation.
- 26 April 2024
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 44 (1) , 2346228
Open AccessProlidase activity in women with polycystic ovarian syndrome undergoing assisted conception
Background: Prolidase is a manganese (Mn)-dependent cytosolic exopeptidase that degrades imidodipeptides with C-terminal proline or hydroxyproline. Prolidase recycling from imidodipeptides plays a critical role in collagen resynthesis and extracellular matrix (ECM) remodelling. Following an increase in gonadotropins, ovarian and follicular collagen undergo substantial degradation. Abnormal ovarian ECM composition is associated with polycystic ovary syndrome (PCOS). This study aimed to examine prolidase activity in the serum and follicular fluid (FF) of women undergoing in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) treatment, comparing those with PCOS to those with normal ovarian function.Methods: This prospective study enrolled 50 participants, of whom 44 were included. PCOS diagnosis followed the Rotterdam consensus criteria, with 20 patients constituting the study group. The control group comprised 24 individuals with mild-to-moderate male infertility. Prolidase enzyme activity in serum and FF was measured using the Chinard reagent via spectrophotometric analysis and compared between the groups.Results: Serum and FF prolidase levels were significantly lower in patients with PCOS (p < 0.05). A direct correlation was observed between serum and FF prolidase levels (p < 0.05). Although blastocyst quality scoring (BQS) significantly decreased in PCOS patients, no statistical difference was observed in the clinical pregnancy rate between the groups (p < 0.05) (p > 0.05). A negative correlation existed between serum prolidase levels and total antral follicle (AF) count (p < 0.05). Conversely, both serum and FF prolidase levels positively correlated with BQS (r = 0.574)(p < 0.05) (r = 0.650)(p < 0.05).Conclusions: Patients with PCOS showed lower serum and FF prolidase levels, indicating abnormal degradation of ovarian and follicular collagen, potentially causing anovulation.
- 29 July 2023
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Can Triglyceride/Glucose Index (TyG) and Triglyceride/HDL-Cholesterol Ratio (TG/HDL-c) Predict Gestational Diabetes Mellitus?
AIM: We investigated whether measurement of triglyceride/glucose index (TyG) and triglyceride/HDL-cholesterol ratio (TG /HDL-c) in the first trimester can predict gestational diabetes mellitus (GDM). MATERIAL AND METHOD: Twenty-five patients with GDM and 52 women without GDM with normal glycemic control during pregnancy were included in the study as a control group. Both insulin-controlled diabetes and diet-controlled diabetes were included in the diagnosis of GDM. Fasting glucose and plasma lipid profiles including TG, HDL-c, TyG index, and TG /HDL-c measured in the first trimester were analyzed. RESULTS: Triglyceride values (mean 133±40 mg/dL in the gestational diabetes group, 100±54 mg/dL in the control group), TyG index (15.0±8.9 in the mean gestational diabetes group, 8.8±5.0 in the control group), and TG/HDL-C ratio (mean 3.3±2.6 in the gestational diabetes group and 1.9±2.6 in the control group) was found to be significantly higher in the GDM group (p=0.01, p=0.01, p=0.01, respectively). The optimal cutoff value for TyG index was 10.4, sensitivity was 76%, specificity was 77%, and area under the receiver characteristic curve (AUC) was 0.765 to predict GDM (p < 0.001). The optimal cutoff value for the TG /HDL-C ratio was 2.3, sensitivity was 76%, specificity was 69, AUC 0.697 to predict GDM (p=0.005). CONCLUSION: TyG and TG/HDL-C ratio measured in the first trimester are thought to predict GDM better than fasting plasma glucose. AMAÇ: Birinci trimesterde trigliserit/glukoz indeksi (TyG) ve trigliserid/HDL-kolesterol oranı (TG /HDL-c) ölçümünün gestasyonel diyabetes mellitusu (GDM) tahmin edip edemeyeceğini araştırdık. GEREÇ VE YÖNTEM: Gebelikte GDM'li 25 hasta ve glisemik kontrolü normal olan GDM'siz 52 hasta kontrol grubu olarak çalışmaya alındı. GDM tanısına hem insülin kontrollü diyabet hem de diyet kontrollü diyabet dahil edildi. İlk trimesterde ölçülen TG, HDL-c, TyG indeksi ve TG /HDL-c'yi içeren açlık glukoz ve plazma lipid profilleri analiz edildi. BULGULAR: Trigliserit değerleri (ortalama gestasyonel diabetes grubunda 133±40 mg/dL, kontrol grubunda 100±54 mg/dL), TyG indeksi (ortalama gestasyonel diabetes grubunda 15,0±8,9, kontrol grubunda 8,8±5,0) ve TG/HDL-K oranı (ortalama gestasyonel diabetes grubunda 3,3±2,6 kontrol grubunda 1,9±2,6) GDM grubunda anlamlı olarak daha yüksek bulundu(sırasıyla p=0.01, p=0.01, p=0.01) GDM'yi öngörmek için TyG indeksi için optimal kesme değeri 10,4, duyarlılık %76, özgüllük %77 ve ROC analizinde eğri altında kalan alan (AUC) 0,765 idi (p < 0,001). GDM'yi öngörmek için TG/HDL-K oranı için optimal kesme değeri 2,3, duyarlılık %76, özgüllük 69, AUC 0,697 idi (p=0,005). SONUÇ: İlk trimesterde ölçülen TyG ve TG/HDL-C oranının GDM'yi açlık plazma glukozundan daha iyi öngördüğü düşünülmektedir.
- 29 July 2023
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Can Triglyceride/Glucose Index (TyG) and Triglyceride/HDL-Cholesterol Ratio (TG/HDL-c) Predict Gestational Diabetes Mellitus?
AIM: We investigated whether measurement of triglyceride/glucose index (TyG) and triglyceride/HDL-cholesterol ratio (TG /HDL-c) in the first trimester can predict gestational diabetes mellitus (GDM). MATERIAL AND METHOD: Twenty-five patients with GDM and 52 women without GDM with normal glycemic control during pregnancy were included in the study as a control group. Both insulin-controlled diabetes and diet-controlled diabetes were included in the diagnosis of GDM. Fasting glucose and plasma lipid profiles including TG, HDL-c, TyG index, and TG /HDL-c measured in the first trimester were analyzed. RESULTS: Triglyceride values (mean 133±40 mg/dL in the gestational diabetes group, 100±54 mg/dL in the control group), TyG index (15.0±8.9 in the mean gestational diabetes group, 8.8±5.0 in the control group), and TG/HDL-C ratio (mean 3.3±2.6 in the gestational diabetes group and 1.9±2.6 in the control group) was found to be significantly higher in the GDM group (p=0.01, p=0.01, p=0.01, respectively). The optimal cutoff value for TyG index was 10.4, sensitivity was 76%, specificity was 77%, and area under the receiver characteristic curve (AUC) was 0.765 to predict GDM (p < 0.001). The optimal cutoff value for the TG /HDL-C ratio was 2.3, sensitivity was 76%, specificity was 69, AUC 0.697 to predict GDM (p=0.005). CONCLUSION: TyG and TG/HDL-C ratio measured in the first trimester are thought to predict GDM better than fasting plasma glucose. AMAÇ: Birinci trimesterde trigliserit/glukoz indeksi (TyG) ve trigliserid/HDL-kolesterol oranı (TG /HDL-c) ölçümünün gestasyonel diyabetes mellitusu (GDM) tahmin edip edemeyeceğini araştırdık. GEREÇ VE YÖNTEM: Gebelikte GDM'li 25 hasta ve glisemik kontrolü normal olan GDM'siz 52 hasta kontrol grubu olarak çalışmaya alındı. GDM tanısına hem insülin kontrollü diyabet hem de diyet kontrollü diyabet dahil edildi. İlk trimesterde ölçülen TG, HDL-c, TyG indeksi ve TG /HDL-c'yi içeren açlık glukoz ve plazma lipid profilleri analiz edildi. BULGULAR: Trigliserit değerleri (ortalama gestasyonel diabetes grubunda 133±40 mg/dL, kontrol grubunda 100±54 mg/dL), TyG indeksi (ortalama gestasyonel diabetes grubunda 15,0±8,9, kontrol grubunda 8,8±5,0) ve TG/HDL-K oranı (ortalama gestasyonel diabetes grubunda 3,3±2,6 kontrol grubunda 1,9±2,6) GDM grubunda anlamlı olarak daha yüksek bulundu(sırasıyla p=0.01, p=0.01, p=0.01) GDM'yi öngörmek için TyG indeksi için optimal kesme değeri 10,4, duyarlılık %76, özgüllük %77 ve ROC analizinde eğri altında kalan alan (AUC) 0,765 idi (p < 0,001). GDM'yi öngörmek için TG/HDL-K oranı için optimal kesme değeri 2,3, duyarlılık %76, özgüllük 69, AUC 0,697 idi (p=0,005). SONUÇ: İlk trimesterde ölçülen TyG ve TG/HDL-C oranının GDM'yi açlık plazma glukozundan daha iyi öngördüğü düşünülmektedir.
- Open Access
- 30 April 2023
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 25 (1) , 45-49
İn Vitro Fertilizasyon/İntrasitoplazmik Sperm Enjeksiyonu Uygulanan Çiftlerde Paternal Yaşın Düşük Oranlarına Etkisi
Aim: The aim of this study was to determine the effect of paternal age on miscarriage rates in couples undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles. Material and Methods: Patients were classified into two groups. The study group consisted of the patients whose pregnancy resulted in a miscarriage (n=73) and a control group in which the patients had a live singleton birth (n=256). Demographic characteristics, treatment indications, duration of infertility, menstruation day 3 follicle stimulating hormone, estradiol, luteinizing hormone, total antral follicle count, anti-Mullerian hormone levels and controlled ovarian stimulation parameters, day of trigger, estradiol and progesterone levels on the day of trigger, the total number of oocytes retrieved, the number of mature oocytes, the number and quality of the embryo, endometrial thickness on the day of trigger, oocyte pick up and embryo transfer, the distance of embryo-fundus and the day of embryo transfer were recorded. Results: Totally 329 women were included in the present study. The number of patients with the diagnosis of unexplained infertility was statistically significantly higher in the study group than in the control group (p=0.020). Maternal age was found statistically significantly higher in the study group than in the control group (p=0.025). When maternal age increased by 1 unit, the risk of miscarriage increased by 8.7% and those with unexplained infertility had a 75.6% higher risk of miscarriage than those without unexplained infertility. Conclusion: Paternal age was not associated with miscarriage whereas maternal age and unexplained infertility had a positive correlation with miscarriage rate.
- 30 April 2023
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 25 (1) , 45-49
Open Accessİn Vitro Fertilizasyon/İntrasitoplazmik Sperm Enjeksiyonu Uygulanan Çiftlerde Paternal Yaşın Düşük Oranlarına Etkisi
Aim: The aim of this study was to determine the effect of paternal age on miscarriage rates in couples undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles. Material and Methods: Patients were classified into two groups. The study group consisted of the patients whose pregnancy resulted in a miscarriage (n=73) and a control group in which the patients had a live singleton birth (n=256). Demographic characteristics, treatment indications, duration of infertility, menstruation day 3 follicle stimulating hormone, estradiol, luteinizing hormone, total antral follicle count, anti-Mullerian hormone levels and controlled ovarian stimulation parameters, day of trigger, estradiol and progesterone levels on the day of trigger, the total number of oocytes retrieved, the number of mature oocytes, the number and quality of the embryo, endometrial thickness on the day of trigger, oocyte pick up and embryo transfer, the distance of embryo-fundus and the day of embryo transfer were recorded. Results: Totally 329 women were included in the present study. The number of patients with the diagnosis of unexplained infertility was statistically significantly higher in the study group than in the control group (p=0.020). Maternal age was found statistically significantly higher in the study group than in the control group (p=0.025). When maternal age increased by 1 unit, the risk of miscarriage increased by 8.7% and those with unexplained infertility had a 75.6% higher risk of miscarriage than those without unexplained infertility. Conclusion: Paternal age was not associated with miscarriage whereas maternal age and unexplained infertility had a positive correlation with miscarriage rate.
- 10 April 2023
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 10 (1) , 42-46
Evaluation of The Effects of Different Progesterone Treatment Methods on Fetal Aneuploidy Screening Tests
In this study, the effect of progesterone use on biomarkers due to abortion complaints in aneuploidy screenings was investigated. Two hundred seventy-six singleton pregnant patients with threatened abortion were enrolled in this retrospective study. The treatment group consisted of patients who received oral, vaginal, or intramuscular progesterone (n=137) while the control group received no progesterone (n=139). The results of the double and triple screening tests of the study groups were compared. Nuchal translucency measurements and pregnancy-associated plasma protein-A (PAPP-A), (MoM) values were significantly lower in the group that received treatment with progesterone compared to the control group (p=0.009 and p<0.001, respectively). Beta-human chorionic gonadotropin (βhCG), (MoM) and alpha-fetoprotein (MoM) were found to be statistically significantly higher in the group receiving oral progesterone treatment compared to the group receiving other types of progesterone treatment (p=0.032 and p=0.001, respectively). The PAPP-A was found to be significantly lower in the oral treatment group (p=0.001). It was also significantly lower in the hydroxyprogesterone caproate treatment group (p=0.013). In the vaginal progesterone treatment group, βhCG was significantly lower (p=0.036) than that in oral treatment group. The study showed that there is a relationship between different progesterone administration routes and fetal aneuploidy screening markers.
- 10 April 2023
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 10 (1) , 42-46
Evaluation of The Effects of Different Progesterone Treatment Methods on Fetal Aneuploidy Screening Tests
In this study, the effect of progesterone use on biomarkers due to abortion complaints in aneuploidy screenings was investigated. Two hundred seventy-six singleton pregnant patients with threatened abortion were enrolled in this retrospective study. The treatment group consisted of patients who received oral, vaginal, or intramuscular progesterone (n=137) while the control group received no progesterone (n=139). The results of the double and triple screening tests of the study groups were compared. Nuchal translucency measurements and pregnancy-associated plasma protein-A (PAPP-A), (MoM) values were significantly lower in the group that received treatment with progesterone compared to the control group (p=0.009 and p<0.001, respectively). Beta-human chorionic gonadotropin (βhCG), (MoM) and alpha-fetoprotein (MoM) were found to be statistically significantly higher in the group receiving oral progesterone treatment compared to the group receiving other types of progesterone treatment (p=0.032 and p=0.001, respectively). The PAPP-A was found to be significantly lower in the oral treatment group (p=0.001). It was also significantly lower in the hydroxyprogesterone caproate treatment group (p=0.013). In the vaginal progesterone treatment group, βhCG was significantly lower (p=0.036) than that in oral treatment group. The study showed that there is a relationship between different progesterone administration routes and fetal aneuploidy screening markers.